Michael O'Reilly is a global health technology leader with deep expertise in the intersection of genomics, digital health, and personalized medicine. We spoke with him about how genomics is transforming healthcare — and what it means for patients seeking truly personalized health management.
How Is Genomics Changing the Healthcare Landscape?
"Genomics is fundamentally shifting healthcare from a reactive, population-based model to a proactive, personalized one," Michael explains. "For most of medical history, we've treated patients based on their diagnosis — giving everyone with the same condition the same treatment. Genomics allows us to treat the individual — understanding their unique biological makeup and tailoring interventions accordingly."
He points to several areas where this shift is already happening. "In oncology, tumor genomic profiling is now standard of care for many cancers — guiding targeted therapy selection based on the specific mutations driving each patient's cancer. In pharmacogenomics, genetic testing is helping doctors choose the right medication at the right dose from the start. In preventive medicine, genetic risk assessment is enabling truly personalized prevention strategies."
What Role Does Consumer Genomics Play?
"Consumer genomics — direct-to-consumer genetic testing — has been transformative in democratizing access to genetic information," Michael says. "Companies like MapMyGenome are making it possible for anyone to understand their genetic health profile without needing a doctor's referral or a hospital visit. This is empowering people to take a more active role in their own health management."
He emphasizes the importance of clinical validity and actionability. "The most valuable consumer genomic tests are those that provide clinically validated insights with clear, actionable recommendations. It's not enough to tell someone they have a genetic variant — you need to tell them what it means for their health and what they can do about it."
What Are the Biggest Opportunities for Genomics in India?
"India is a particularly exciting market for genomics," Michael says. "The genetic diversity of the Indian population is extraordinary — and much of it is understudied. Building India-specific genomic databases and reference populations is critical for ensuring that genetic insights are accurate and relevant for Indian patients."
He also highlights the opportunity in pharmacogenomics. "India has one of the highest burdens of adverse drug reactions globally. Pharmacogenomic testing could prevent a significant proportion of these reactions — saving lives and reducing healthcare costs. The challenge is integrating pharmacogenomic testing into routine clinical practice."
What Advice Do You Have for Individuals Interested in Genomic Health?
"Start with a comprehensive genetic health test from a reputable provider," Michael advises. "Look for tests that cover a broad range of health conditions, are backed by clinical evidence, and provide actionable recommendations. Then work with a healthcare provider who can help you interpret the results and integrate them into your health management plan."
Start Your Personalized Health Journey with Your DNA
Genomepatri by MapmyGenome is India's most comprehensive at-home DNA wellness test — covering 100+ health conditions, drug responses, and lifestyle traits with clinically validated, actionable insights.
